Arglabin, a plant-derived compound, inhibited the activity of the NLRP3 inflammasome and significantly reduced the production of IL-1α, IL-1β, and IL-18, reducing the production of proinflammatory mediators to alleviate atherosclerosis [73]. The gene discussed is IL1B; the disease is atherosclerosis.